Contribute Try STAT+ Today

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is somewhat ambitious. Besides puttering about the grounds and promenading with the official mascot, we plan to visit the Pharmalot ancestors and catch up on our reading. And what about you? This is a fine time to enjoy the great outdoors — beaches, lakes, and mountains are beckoning. You could also plan a summer getaway. Or make plans to take in a ball game or outdoor concert. Well, whatever you do, have a grand time. But be safe. And if dad is around, remember to say hello. …

Two-thirds of Americans who are familiar with the details of the newly approved Alzheimer’s treatment believe the medication will be effective, but a similar percentage have concerns about the regulatory process used to endorse the drug and people are divided over whether the drug, which will cost $56,000, is fairly priced, according to a new survey from STAT and The Harris Poll. Among those who had only heard about the approval, slightly more than half agree the drug will be effective.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Create a display name to comment

This name will appear with your comment